Immunophenotyping of Plasma Cells

@article{Rawstron2006ImmunophenotypingOP,
  title={Immunophenotyping of Plasma Cells},
  author={Andy C. Rawstron},
  journal={Current Protocols in Cytometry},
  year={2006},
  volume={36}
}
  • A. Rawstron
  • Published 1 April 2006
  • Biology
  • Current Protocols in Cytometry
Plasma cell enumeration and immunophenotyping has been shown to be of value in predicting the outcome for patients with myeloma. Detection of abnormal plasma cells at a leukocyte level >0.01% at the end of therapy predicts early relapse. Although clonally related populations at varying stages of differentiation are reported to be present in myeloma, only the CD138+ fraction has been shown to directly correlate with the outcome. In addition, the plasma cell immunophenotype in monoclonal… 
Immunophenotype of Normal and Myelomatous Plasma-Cell Subsets
TLDR
The vast heterogeneity of MM PCs possibly accounting for the various answers to therapy of MM patients is underline, as the various subsets delineated by the selective or common expression of CD19 together with combined CD56/CD28 were explored.
Circulating memory B cells and plasmablasts are associated with the levels of serum immunoglobulin in patients with ulcerative colitis
TLDR
The numbers of circulating IgG+ IgD− CD27+ CD19+ memory B cells were significantly increased following treatment with mesalazine, while the numbers of CD138+ CD38+ CD20−CD19+ and IgG- CD38-CD20− CD19- plasmablasts may be involved in the pathogenic process of UC.
Simplified flow cytometric immunophenotyping panel for multiple myeloma, CD56/CD19/CD138(CD38)/CD45, to differentiate neoplastic myeloma cells from reactive plasma cells
TLDR
The simplified immunophenotyping panel, CD56/CD19/CD138(CD38)/CD45, is useful for distinguishing neoplastic myeloma cells from reactive plasma cells in clinical practice and CD19 represents the most valuable antigen for identifying neoplasia cells in patients with MM.
Circulating plasma cells predict the outcome of relapsed or refractory multiple myeloma
TLDR
Non-reduction of aCPCs in patients with RR MM after the first cycle of therapy may be useful in early identification of patients resistant to a given therapy.
Evaluation of CD229 as a new alternative plasma cell gating marker in the flow cytometric immunophenotyping of monoclonal gammopathies
TLDR
The utility of CD229 as a new PC‐gating marker in routine laboratory practice was evaluated and it was found that it did not significantly alter the outcome of previous studies using this marker.
OMIP‐043: Identification of human antibody secreting cell subsets
  • J. Carrell, C. Groves
  • Biology
    Cytometry. Part A : the journal of the International Society for Analytical Cytology
  • 2018
TLDR
The panel was optimized primarily to determine the frequency and immunophenotype of antibody secreting cells (ASC), historically called plasma B cells, and has been shown to be applicable to fresh and cryopreserved peripheral blood, spleen, bone marrow, and tonsil cells.
Six color flow cytometry detects plasma cells expressing aberrant immunophenotype in bone marrow of healthy donors
Both normal and malignant plasma cell (PC) populations can be identified using modern flow cytometry (FC) technique in multiple myeloma (MM) patients. Expression of CD19 and CD56 markers is
Single tube, six-color flow cytometric analysis is a sensitive and cost-effective technique for assaying clonal plasma cells.
TLDR
In cases in which 6-color flow cytometric analysis improved detection of a clonal population, concurrent biopsy showed less than 5% involvement by plasma cell myeloma, suggesting that 6- color flow cytometry has an advantage in patients with a low disease burden.
...
...

References

SHOWING 1-10 OF 15 REFERENCES
Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma.
TLDR
The number of residual polyclonal PCs was the most powerful single parameter for the discrimination between MGUS and MM patients at diagnosis, even when only stage I MM cases were considered.
Primary plasma cell leukemia: clinical, immunophenotypic, DNA ploidy, and cytogenetic characteristics.
TLDR
It is illustrated that PCs from PCL display singular phenotypic, DNA cell content, and cytogenetic characteristics that lead to a different disease evolution versus MM.
Immunophenotypic evaluation of the plasma cell compartment in multiple myeloma: a tool for comparing the efficacy of different treatment strategies and predicting outcome.
TLDR
This approach compared the efficacy of high-dose chemotherapy followed by autologous stem cell transplantation (ASCT) with that of conventional chemotherapy and found that ASCT provided a significantly greater reduction in the level of residual tumor PCs and with better recovery of normal PCs.
CD19 and immunophenotype of bone marrow plasma cells in monoclonal gammopathy of undetermined significance.
TLDR
Many of the so-called pre-B, B or activation antigens are present on plasma cells from MGUS specimens, and expression of CD9, CD10, CD20, CD22, MB2, and CD38 in MGUS was very similar to that in multiple myeloma.
Flow cytometric disease monitoring in multiple myeloma: the relationship between normal and neoplastic plasma cells predicts outcome after transplantation.
TLDR
Analysis of normal and neoplastic plasma cell levels is more sensitive than immunofixation and can identify which patients may benefit from additional treatment strategies at an early stage after transplantation.
Phenotypic difference of normal plasma cells from mature myeloma cells.
TLDR
Both CD19+CD56- and CD19-DC56+ plasma cells were found in all five cases of MGUS the authors tested, suggesting that MGUS consists of phenotypically normal plasma cells and myeloma cells.
CD27 is heterogeneously expressed in multiple myeloma: low CD27 expression in patients with high‐risk disease
TLDR
Fluorescence‐activated cell sorting and allele‐specific oligonucleotide polymerase chain reaction showed that both CD27+ and CD27– PC subpopulations in MM can belong to the clonal disorder.
In Multiple Myeloma Clonotypic CD38 − /CD19 + /CD27 +  Memory B Cells Recirculate Through Bone Marrow, Peripheral Blood and Lymph Nodes
TLDR
Clonotypic memory B-cells were present in the majority of myeloma patients and seem to have the same diverse recirculating/homing capacity as normal memory B cells.
Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group
TLDR
The International Myeloma Working Group has reviewed the criteria for diagnosis and classification with the aim of producing simple, easily used definitions based on routinely available investigations to facilitate comparison of therapeutic trial data.
The proliferative potential of myeloma plasma cells manifest in the SCID-hu host.
TLDR
Although the studies clearly demonstrate the proliferative potential of myeloma plasma cells, they are suggestive, not conclusive, as to the existence of a preplasmacyticMyeloma progenitor cell.
...
...